Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine once-daily vs twice-daily in moderate to severe Alzheimer's disease
CTR20150472Phase 4Completed
- Sponsor
- Lundbeck
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of memantine in Alzheimer's disease (AD), sponsored by Lundbeck. Started Jul 2015; status: completed.
02
Drugs
memantine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20150472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150472.